285 related articles for article (PubMed ID: 31471750)
1. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
[TBL] [Abstract][Full Text] [Related]
2. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.
Yao J; Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J
Am J Respir Crit Care Med; 2014 Dec; 190(11):1273-82. PubMed ID: 25329516
[TBL] [Abstract][Full Text] [Related]
3. Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis.
Gopalakrishnan V; Yao J; Steagall WK; Avila NA; Taveira-DaSilva AM; Stylianou M; Chen MY; Moss J
Chest; 2019 May; 155(5):962-971. PubMed ID: 30660784
[TBL] [Abstract][Full Text] [Related]
4. A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.
Argula RG; Kokosi M; Lo P; Kim HJ; Ravenel JG; Meyer C; Goldin J; Lee HS; Strange C; McCormack FX;
Ann Am Thorac Soc; 2016 Mar; 13(3):342-9. PubMed ID: 26799509
[TBL] [Abstract][Full Text] [Related]
5. Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus.
Takia L; Jat KR; Mandal A; Kabra SK
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413450
[TBL] [Abstract][Full Text] [Related]
6. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
Taveira-DaSilva AM; Hathaway O; Stylianou M; Moss J
Ann Intern Med; 2011 Jun; 154(12):797-805, W-292-3. PubMed ID: 21690594
[TBL] [Abstract][Full Text] [Related]
7. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.
Harari S; Elia D; Torre O; Bulgheroni E; Provasi E; Moss J
Chest; 2016 Aug; 150(2):e29-32. PubMed ID: 27502989
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).
Baldi BG; Araujo MS; Freitas CS; da Silva Teles GB; Kairalla RA; Dias OM; Pereira DA; Pimenta SP; Carvalho CR
Lung; 2014 Dec; 192(6):967-74. PubMed ID: 25201087
[TBL] [Abstract][Full Text] [Related]
10. Durability of Sirolimus for Lymphangioleiomyomatosis.
Martirossian A; Shah S; Carrete L; Valle J; Valentine V
Am J Med Sci; 2017 Dec; 354(6):603-607. PubMed ID: 29208258
[TBL] [Abstract][Full Text] [Related]
11. Cyst-based measurements for assessing lymphangioleiomyomatosis in computed tomography.
Lo P; Brown MS; Kim H; Kim H; Argula R; Strange C; Goldin JG
Med Phys; 2015 May; 42(5):2287-95. PubMed ID: 25979023
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
Bissler JJ; McCormack FX; Young LR; Elwing JM; Chuck G; Leonard JM; Schmithorst VJ; Laor T; Brody AS; Bean J; Salisbury S; Franz DN
N Engl J Med; 2008 Jan; 358(2):140-51. PubMed ID: 18184959
[TBL] [Abstract][Full Text] [Related]
13. Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis.
Matthew BP; Hasani AM; Chen YC; Pirooznia M; Stylianou M; Rollison SF; Machado TR; Quade NM; Jones AM; Julien-Williams P; Taveira-DaSilva A; Chen MY; Moss J; Wen H
Chest; 2021 Jul; 160(1):199-208. PubMed ID: 33549601
[TBL] [Abstract][Full Text] [Related]
14. Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis.
Schmithorst VJ; Altes TA; Young LR; Franz DN; Bissler JJ; McCormack FX; Dardzinski BJ; Brody AS
AJR Am J Roentgenol; 2009 Apr; 192(4):1037-44. PubMed ID: 19304711
[TBL] [Abstract][Full Text] [Related]
15. Severity and outcome of cystic lung disease in women with tuberous sclerosis complex.
Taveira-DaSilva AM; Jones AM; Julien-Williams P; Yao J; Stylianou M; Moss J
Eur Respir J; 2015 Jan; 45(1):171-80. PubMed ID: 25537563
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Treatment response to Sirolimus in pulmonary lymphangioleiomyomatosis by longitudinal quantification of cystic changes using automated post-processing of chest CT-data.
Albtoush OM; Horger M
Rofo; 2020 Dec; 192(12):1202-1204. PubMed ID: 32408352
[No Abstract] [Full Text] [Related]
17. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between Birt-Hogg-Dubé syndrome and lymphangioleiomyomatosis: quantitative analysis of pulmonary cysts on computed tomography of the chest in 66 females.
Tobino K; Hirai T; Johkoh T; Kurihara M; Fujimoto K; Tomiyama N; Mishima M; Takahashi K; Seyama K
Eur J Radiol; 2012 Jun; 81(6):1340-6. PubMed ID: 21550193
[TBL] [Abstract][Full Text] [Related]
19. Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex.
Adriaensen ME; Schaefer-Prokop CM; Duyndam DA; Zonnenberg BA; Prokop M
Clin Radiol; 2011 Jul; 66(7):625-8. PubMed ID: 21459371
[TBL] [Abstract][Full Text] [Related]
20. Cyst Ventilation Heterogeneity and Alveolar Airspace Dilation as Early Disease Markers in Lymphangioleiomyomatosis.
Walkup LL; Roach DJ; Hall CS; Gupta N; Thomen RP; Cleveland ZI; McCormack FX; Woods JC
Ann Am Thorac Soc; 2019 Aug; 16(8):1008-1016. PubMed ID: 31038987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
